GPR78

Chr 4

G protein-coupled receptor 78

The protein is an orphan G protein-coupled receptor that displays significant constitutive activity and stimulates adenylate cyclase through G(s)-alpha protein, resulting in elevated intracellular cAMP levels. Mutations cause autosomal recessive intellectual disability with seizures and hypotonia. This gene is highly constrained against loss-of-function variation, suggesting mutations are likely to have significant clinical impact.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
8
Pubs (1 yr)
75
P/LP submissions
0%
P/LP missense
1.82
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryGPR78
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
75 unique Pathogenic / Likely Pathogenic· 106 VUS of 191 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.82LOEUF
pLI 0.000
Z-score -0.31
OE 1.12 (0.651.82)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-1.25Z-score
OE missense 1.22 (1.111.35)
301 obs / 245.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.12 (0.651.82)
00.351.4
Missense OE1.22 (1.111.35)
00.61.4
Synonymous OE1.22
01.21.6
LoF obs/exp: 8 / 7.1Missense obs/exp: 301 / 245.7Syn Z: -1.90
DN
0.6743th %ile
GOF
0.84top 5%
LOF
0.3067th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

191 submitted variants in ClinVar

Classification Summary

Pathogenic72
Likely Pathogenic3
VUS106
Likely Benign6
Benign3
72
Pathogenic
3
Likely Pathogenic
106
VUS
6
Likely Benign
3
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
72
0
72
Likely Pathogenic
0
0
3
0
3
VUS
0
94
12
0
106
Likely Benign
0
3
2
1
6
Benign
0
0
0
3
3
Total097894190

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

GPR78 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →